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Abstract. We stimulated human erythrocytes obtained from patients with hypercholesterolemia (HC; n = 42), renal trans-
plantation (RT; n = 18) and hypertension (HT; n = 10) with acetylcholine (ACh 10 µM) and measured the amperometric
NO production, comparing with the NO levels achieved on erythrocytes of healthy persons (n = 27). We also measured
the hemoglobin, hematocrit, erythrocyte aggregation, erythrocyte deformability, plasma viscosity and fibrinogen concentration
from human blood samples. The erythrocytes NO levels were of 2.5 ± 0.7 nM (P = 0.038, HC), 2.4 ± 1.1 nM (RT) and
2.2 ± 0.8 nM (HT) against the 2.0 ± 0.8 nM for the control groups. For each group and at each shear stress value, the ery-
throcytes deformability decreases with the increase of the NO concentration after ACh stimulation. We observed a significant
increase of the control values on the erythrocyte aggregation results on each patient group. Besides the lower erythrocyte de-
formability obtained on HC, RT and HT blood samples, the erythrocytes produced higher NO levels after ACh stimulation
than the healthy ones. The power of erythrocyte hemorheological behaviour could be compensated by the NO production at the
presence of acetylcholine. We can hypothesises that cholinergic drugs could be used as co-adjuvants of specific therapeutics
compounds on these studied diseases.
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1. Introduction
Several endothelium-derived substances have been isolated causing smooth muscle relaxation. Nitric
oxide is one of them and its biosynthesis pathway is well characterized [1,2]. Nitric oxide is a relatively
stable gas, with ability to diffuse through the cell membrane [2]. Reaction of vascular-derived NO with
hemoglobin is believed to be the most important pathway for limiting NO bioactivity. The reaction of
the iron-containing heme groups of oxy- and deoxyhemoglobin with NO produces, respectively, methe-
moglobin and nitrate ions and iron-nitrosyl-hemoglobin [3]. The process of NO diffusion through the
cell membrane followed by diffusion through plasma and the chemical reaction with erythrocyte inter-
nal hemoglobin indicates that changes in membrane permeability and in other hemorheological parame-
ters could occur [4,5]. The changes in hemorheologic properties of the erythrocytes have physiological
relevance because they induce modifications in blood viscosity, modulate blood distribution in several
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vascular territories and tissue oxygenation [6]. Erythrocytes may release NO bound to hemoglobin in the
microcirculation under low oxygen tension [7]. In 1980, Furchgott and Zawadzki reported that acetyl-
choline (ACh) causes relaxation of isolated blood vessels only in presence of an intact endothelial cell
layer [8]. Acetylcholine infusions to forearm blood flow are used to evaluate the endothelial cells lay-
ers function [9]. This vasomotor response is NO dependent and the loss of its biological activity and
biosynthesis is one of the mechanisms responsible of endothelial dysfunction. Depressed endothelium
dependent vascular relaxation is present in patients with essential hypertension [10,11]. Atherosclerosis,
hypertension, diabetes, reperfusion injury and vasculopathy as well as angioplasty, bypass surgery, and
transplantation are examples of diseases where NO insufficiency induces endothelium dysfunction [12].
There is increasing evidence of associations between hemorheological parameters and hypertension [13].
The development of hypertension in patients submitted to renal transplantation is also described [14].
Our previous in vitro studies shown that ACh decrease erythrocyte aggregation, increase erythrocyte
deformability and decrease hemoglobin affinity to oxygen [2]. Here we study the relation between the
NO production, achieved by in vitro erythrocyte ACh stimulation, and the changes on hemorheological
parameters, in blood from patients with hypercholesterolemia, renal transplantation and hypertension.
2. Materials and methods
The hypercholesterolemic patients (n = 42) were 25 females and 17 males with the mean age of
52 years (SD = 13). The patients that were submitted to a renal transplantation (n = 18) have the
mean age of 39 years (SD = 15) and were 8 females and 10 males. The patients with hypertension
(n = 10) were 6 females and 4 males with the mean age of 56 years (SD = 8). The mean ages of
the controls (healthy persons, n = 27) was 34 years (SD = 7) and were 10 females and 17 males.
All the subjects gave their informed consent to participate in this study. We used the amiNO-IV sensor
(Innovative Instruments, Inc., FL, USA) to quantify the erythrocytes NO production and the method
was described at Carvalho et al. [15]. The erythrocyte deformability was measured at 22◦C using the
Rheodyn SSD laser diffractometer (Myrenne, Roetgen, Germany [16]). The erythrocyte aggregation was
measured at 22◦C with a MA1 aggregometer (Myrenne, Roetgen, Germany). The plasma viscosity of the
samples was measured using a capillary viscometer (Coulter Electronics, Luton, UK) according to the
Harkness method [17]. The fibrinogen concentration was measured in a Fibrintimer (Behring Institute,
Newark, USA), using a modification of the Clauss’s method. Statistical significances were examined
using Student’s t tests, for paired observations, performed with use of the SPSS 10. All patient samples
were tested against the control. Statistical significance was considered for values of P < 0.05. The
results are presented as means ± SD (standard deviation).
3. Results
The NO concentration values obtained from in vitro erythrocytes stimulation with ACh 10 µM are
described in Fig. 1. The results in Table 1 revealed that there were no significant difference between
the hemoglobin and the hematocrit values of the patients groups and the control group. The erythrocyte
deformability of the patients groups decreased the control values, at each shear stress values (vd Fig. 2).
For each group and at each shear stress value, the erythrocytes deformability decreases with the increase
of the NO concentration after ACh stimulation (vd. Fig. 4). The erythrocyte aggregation values for each
patient group significant increased the control values (vd. Fig. 3). The plasma viscosity results (Table 1)
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Fig. 1. Nitric oxide concentrations of erythrocytes suspensions (Ht = 0.05%) after in vitro erythrocytes stimulation with ACh
10 µM. Comparation of the NO values between hypercholesterolemic, renal transplantation or hypertension patients and the
control (healthy persons). Values are in mean ± SD.
Table 1
Hemoglobin (g/dl), hematocrit (%), plasma viscosity (mPa.s) and fibrinogen concentration (mg/dl), of hypercholesterolemic,
renal transplantation, hypertension and control (healthy persons) blood samples. Values are in mean ± SD
Groups Hb Ht Plasma viscosity Fibrinogen
(g/dl) (%) (mPa.s) (mg/dl)
Control (n = 27) 13.7± 1.2 43.0± 3.6 1.24± 0.04 273.7± 55.4
Hypercholesterolemia (n = 42) 13.9± 1.2 42.5± 3.5 1.26± 1.041 310.0± 64.74
Renal transplantation (n = 18) 13.2± 1.8 41.2± 4.9 1.26± 0.042 294.0± 65.0
Hypertension (n = 10) 14.5± 1.3 42.9± 3.8 1.27± 0.033 287.0± 65.0
1Significant difference relatively to the control samples (P = 0.035); 2Significant difference relatively to the control samples
(P = 0.045); 3Significant difference relatively to the control samples (P = 0.034); 4Significant difference relatively to the
control samples (P = 0.027).
Fig. 2. Erythrocyte deformability at shear stress values of 0.6, 6 and 30 mPa, of patients with hypercholesterolemia, renal
transplantation and hypertension versus control values. Values are in mean ± SD.
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Fig. 3. Erythrocyte aggregation of patients with hypercholesterolemia, renal transplantation and hypertension versus control
values. The erythrocyte aggregation was measured at 5 and 10 seconds of shear rate exposure. Values are in mean ± SD.
showed a significant increase of control values for the HC, RT and HT group. For HC group, there was
a significant increase of the fibrinogen concentration control values (vd. Table 1).
4. Discussion
In this study, we observed the relation between the erythrocyte NO production and the changes of
hemorheological properties in patients with hypercholesterolemia, renal transplantation and hyperten-
sion. In each of these dysfunctions, there was an increase in erythrocytes NO production after in vitro
ACh stimulation, although only in the hypercholesterolemic group these results were significant. Re-
cent studies suggested that LDL might inhibit endothelium-dependent relaxation through inactivation of
NO [18]. In addition, oxidized LDL forms specifically impair NO-dependent arterial relaxation through
different mechanisms [19]. Our results showed that on hypercholesterolemic patients, there were signifi-
cant increases on erythrocyte aggregation, plasma viscosity and fibrinogen concentration and a decrease
on erythrocyte deformability. Previous reports showed that enrichment of cholesterol/phospholipids in-
crease erythrocyte suspensions viscosity and decrease erythrocyte deformability [20]. From our results
of hypercholesterolemic patients (vd. Figs 1–4), we can predict that physiological repercussions of a
higher erythrocyte aggregation increased and a lower erythrocyte are attenuated with changes on ery-
throcytes NO production or vice versa. Erythrocytes were able to produce high NO levels even when
erythrocyte deformability is decreased and low NO concentrations when erythrocyte aggregation is in-
creased (vd. Fig. 4). The results of renal transplantation patients revealed that there was an increased of
the erythrocyte aggregation and plasma viscosity and a decreased of erythrocyte deformability values
(vd. Figs 2, 3 and Table 1), which were in accordance with the work of Linde et al. [21]. The changes
on hemorheological parameters and on NO concentration may play an important role on the develop-
ment of a hypertensive state [22], that can suggest a future target for vasodilating therapeutic action on a
microcirculatory network, damaged by different sorts of stimulus. A vascular response to acetylcholine
could be modulated by blood pressure normalization [23]. In rat mesenteric resistance arteries, hyperten-
sion was associated with an increased of NO oxidation by O·¯2, whereas NO production remained largely
unaffected [24]. During hypertension due to aortic banding, a slightly increased of endothelial NOS
expression was found [25]. Our hemorheological results were in accordance with other authors, which
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Fig. 4. Values of erythrocyte deformability at shear stress values of 0.6 Pa, 6 Pa and 30 Pa of hypercholesterolemic (A), renal transplantation (B) and hypertensive
(C) patients.
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showed that the blood and plasma viscosities and erythrocyte aggregation were increased, while erythro-
cyte deformability decreased, on hypertension patients [26,27]. In agreement with these results, we may
suppose that the erythrocyte aggregation of hypertension group could be related with changes on ery-
throcytes NO production. There was a higher tendency to erythrocytes aggregate and lower ability to NO
production, after ACh stimulation. The hypothesis that acetylcholine, besides its different physiological
functions, could participate in transmembrane signalling process, inducing changes on NO production
simultaneously with perturbations in aggregation/disaggregation forces and facilitating the erythrocyte
deformability, are still unclear. The power of erythrocyte hemorheological behaviour could be compen-
sated by the NO production at the presence of acetylcholine. We could hypothesize that cholinergic
drugs could be used as co-adjuvants of specific therapeutics compounds in hypercholesterolemia, renal
transplantation and hypertension diseases.
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